Sepsis News and Research

Latest Sepsis News and Research

Penn scientists to explore new approach for predicting and treating diseases at individual level

A new National Institutes of Health High-Risk, High-Reward grant will allow Penn State's Steven Schiff and team to explore a radically changed approach to predicting, preventing and treating infectious disease at the individual level at point-of-care.

3 Oct 2018

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Seattle Genetics, Inc. and Takeda Pharmaceutical Company Limited announced today that the phase 3 ECHELON-2 clinical trial met its primary endpoint.

1 Oct 2018

Gangrene-causing bacteria show promise as cancer treatment

Researchers have found that the bacteria responsible for causing gangrene could also be used to treat patients with certain cancers.

1 Oct 2018

$Bacterial therapy shows early clinical efficacy in patients with treatment-refractory solid tumors$

Bacterial therapy shows early clinical efficacy in patients with treatment-refractory solid tumors

A phase I clinical trial investigating the use of bacterial Clostridium novyi-NT spores as an injectable monotherapy had manageable toxicities and showed early clinical efficacy in patients with treatment-refractory solid tumor malignancies, according to data presented at the Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival, held Sept. 30-Oct. 3.

30 Sep 2018

Critical illness and major infection can promote brain changes, accelerate cognitive decline

Researchers at Johns Hopkins report that a novel analysis of more than a thousand patients adds to evidence that hospitalization, critical illness and major infection may diminish brain structures that are most commonly affected by Alzheimer's disease.

28 Sep 2018

GARDP partners with Novartis to accelerate development of generic antibiotic treatments for children

The Global Antibiotic Research & Development Partnership and Novartis are joining forces to accelerate the development and availability of generic antibiotic treatments for children in low- and middle-income countries.

27 Sep 2018

Scientists discover most important target of MRSA bacterial toxin and ways to neutralize it

For patients diagnosed with a Staphylococcus aureus infection, often referred to as a staph or MRSA infection, every minute counts.

27 Sep 2018

Diabetes patients with poor blood sugar control face highest risk of serious infections

A new study has shown that diabetes patients with the poorest control of their blood sugars face the highest risks of hospitalization and death due to infections.

26 Sep 2018

Genomic ‘islands’ evolved from viruses can be converted into ‘anti-bacterial drones’

Genomic "islands" that evolved from viruses can be converted into "drones" that disable Staphylococcus aureus, bacteria that are often resistant to antibiotics and pose a threat to safe hospital care, a new study finds.

25 Sep 2018

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

Seattle Genetics, Inc. today announced that its collaborator, Takeda Pharmaceutical Company Limited, has received approval from the Japanese Ministry of Health, Labour and Welfare for ADCETRIS (brentuximab vedotin) in combination with doxorubicin, vinblastine and dacarbazine as a frontline treatment option for CD30-positive Hodgkin lymphoma patients in Japan.

24 Sep 2018

$CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL$

CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL

AbbVie, a research-based global biopharmaceutical company, announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has granted a positive opinion for VENCLYXTO® in combination with rituximab for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia who have received at least one prior therapy.

21 Sep 2018

Despite red flags at surgery centers, overseers award gold seals

At his surgery center near San Diego, Rodney Davis wore scrubs, was referred to as "Dr. Rod" and carried the title of director of surgery. But he was a physician assistant, not a doctor, who anesthetized patients and performed liposuction with little input from his supervising doctor, court records show.

20 Sep 2018

Ipsen receives approval from Health Canada for CABOMETYX tablets for treating renal cell carcinoma

Exelixis, Inc. today announced that its partner Ipsen Biopharmaceuticals Canada Inc. received approval from Health Canada of CABOMETYX® tablets for the treatment of adults with advanced renal cell carcinoma who have received prior vascular endothelial growth factor targeted therapy.

19 Sep 2018

New technology rapidly assesses antibiotics by using bacteria in bear saliva

If you're looking into the mouth of a brown bear, one of the world's top predators, your chances of survival probably aren't good. But a team of Rutgers and other scientists has discovered a technology that rapidly assesses potentially lifesaving antibiotics by using bacteria in saliva from an East Siberian brown bear.

14 Sep 2018

'Clinical Early Warning Scores' to predict future deterioration of patients

Doctors and nurses are always grateful when they are given advance notice that a patient is about to seriously deteriorate (or 'crash', to use today's clinical vernacular).

14 Sep 2018

Annual survey highlights poor awareness of sepsis in the US

A new survey has revealed that, although awareness of sepsis is increasing in the US, there are still very few people who are able to recognize the symptoms.

13 Sep 2018

MilliDrop awarded €1.9 million to accelerate development of blood infection diagnosis system

MilliDrop, which designs and develops cell culture solutions based on millifluidics technology for bacteriological research and diagnosis purposes, announces it has been awarded €1.9 million in non-dilutive financing from Bpifrance to accelerate the development of its blood infection diagnosis system for sepsis.

12 Sep 2018

Researchers develop mathematical model for monitoring, controlling spread of melioidosis

An international research team from the University of Leicester, Lomonosov Moscow State University, and the Moscow Institute of Physics and Technology from Russia has developed a mathematical model for monitoring and controlling the spread of melioidosis in Southeast Asia.

12 Sep 2018

Stimuli-responsive nanoparticles can specifically target infections to prevent spread of bacteria

Current WSU research shows stimuli-responsive nanoparticles can specifically target infections to simultaneously prevent the spread of bacteria and reduce the inflammation it causes.

12 Sep 2018

Enabling Patient Care in the Community Through Technology

An interview with Diane Hargrove and Sophie Lindvold at the NHS Health and Care Expo 2018 about how the technologies offered by BES Healthcare can be used to safely discharge patients from acute care and monitor their health status in the community.

From BES Healthcare Ltd 11 Sep 2018

Sepsis News and Research

Latest Sepsis News and Research

Penn scientists to explore new approach for predicting and treating diseases at individual level

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Gangrene-causing bacteria show promise as cancer treatment

Bacterial therapy shows early clinical efficacy in patients with treatment-refractory solid tumors

Critical illness and major infection can promote brain changes, accelerate cognitive decline

GARDP partners with Novartis to accelerate development of generic antibiotic treatments for children

Scientists discover most important target of MRSA bacterial toxin and ways to neutralize it

Diabetes patients with poor blood sugar control face highest risk of serious infections

Genomic ‘islands’ evolved from viruses can be converted into ‘anti-bacterial drones’

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL

Despite red flags at surgery centers, overseers award gold seals

Ipsen receives approval from Health Canada for CABOMETYX tablets for treating renal cell carcinoma

New technology rapidly assesses antibiotics by using bacteria in bear saliva

'Clinical Early Warning Scores' to predict future deterioration of patients

Annual survey highlights poor awareness of sepsis in the US

MilliDrop awarded €1.9 million to accelerate development of blood infection diagnosis system

Researchers develop mathematical model for monitoring, controlling spread of melioidosis

Stimuli-responsive nanoparticles can specifically target infections to prevent spread of bacteria

Enabling Patient Care in the Community Through Technology

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Sepsis News and Research

Latest Sepsis News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in